194 related articles for article (PubMed ID: 26149860)
21. Antibodies elicited during natural infection in a predominantly Plasmodium falciparum transmission area cross-react with sexual stage-specific antigen in P. vivax.
Bansal GP; Vengesai A; Cao Y; Mduluza T; Kumar N
Acta Trop; 2017 Jun; 170():105-111. PubMed ID: 28257812
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein.
Cheng Y; Wang B; Lu F; Ahmed MA; Han JH; Na SH; Ha KS; Park WS; Hong SH; Han ET
Parasit Vectors; 2019 Apr; 12(1):176. PubMed ID: 30999945
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
[TBL] [Abstract][Full Text] [Related]
24. Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax.
Kumar N; Folgar JP; Lubega P
Am J Trop Med Hyg; 1992 Oct; 47(4):422-8. PubMed ID: 1279995
[TBL] [Abstract][Full Text] [Related]
25. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
[TBL] [Abstract][Full Text] [Related]
26. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
[TBL] [Abstract][Full Text] [Related]
27. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
[TBL] [Abstract][Full Text] [Related]
28. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
29. A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites
Shen FH; Ong JJY; Sun YF; Lei Y; Chu RL; Kassegne K; Fu HT; Jin C; Han ET; Russell B; Han JH; Cheng Y
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199351
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
[TBL] [Abstract][Full Text] [Related]
31. Anti-MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon.
Rosas-Aguirre A; Patra KP; Calderón M; Torres K; Gamboa D; Arocutipa E; Málaga E; Garro K; Fernández C; Trompeter G; Alnasser Y; Llanos-Cuentas A; Gilman RH; Vinetz JM
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31770108
[TBL] [Abstract][Full Text] [Related]
32. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.
Lima-Junior JC; Jiang J; Rodrigues-da-Silva RN; Banic DM; Tran TM; Ribeiro RY; Meyer VS; De-Simone SG; Santos F; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2011 Feb; 29(9):1801-11. PubMed ID: 21215342
[TBL] [Abstract][Full Text] [Related]
33. Immunoprofiling of the tryptophan-rich antigen family in Plasmodium vivax.
Wang B; Lu F; Cheng Y; Chen JH; Jeon HY; Ha KS; Cao J; Nyunt MH; Han JH; Lee SK; Kyaw MP; Sattabongkot J; Takashima E; Tsuboi T; Han ET
Infect Immun; 2015 Aug; 83(8):3083-95. PubMed ID: 25987709
[TBL] [Abstract][Full Text] [Related]
34. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
[TBL] [Abstract][Full Text] [Related]
35. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS; Oliveira SG; Souza JM; Rodrigues MM
Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
[TBL] [Abstract][Full Text] [Related]
37. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
[TBL] [Abstract][Full Text] [Related]
38. Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens.
Hall CE; Hagan LM; Bergmann-Leitner E; Tosh DM; Bennett JW; Regules JA; Chuang I; Angov E; Dutta S; Chattopadhyay D; Yadava A
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30559218
[TBL] [Abstract][Full Text] [Related]
39. Assessment of IgG3 as a serological exposure marker for
Tayipto Y; Rosado J; Gamboa D; White MT; Kiniboro B; Healer J; Opi DH; Beeson JG; Takashima E; Tsuboi T; Harbers M; Robinson L; Mueller I; Longley RJ
Front Cell Infect Microbiol; 2022; 12():950909. PubMed ID: 36017364
[TBL] [Abstract][Full Text] [Related]
40. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
